Skip to content

Author

Hyung-Muck Kang

1 paper indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Sep 2026

Vitamin C selectively eliminates erlotinib-induced drug-tolerant persister cells via CERK and KRT82 regulation in EGFR-mutant non-small cell lung cancer

Despite the efficacy of epidermal growth factor receptor (EGFR)-tyrosine kinase inhibitor (TKI) erlotinib in EGFR -mutant non-small cell lung cancer (NSCLC) patients, a subset of drug-tolerant persister (DTP) cells remains. While protein alterations unique to DTPs are crucial for their survival, the mechanisms re...

Hyung-Muck Kang · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.